Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Biogen Inc

Recent news which mentions Biogen Inc

< Previous 1 2 3 Next >
Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more
Tags Market Insider DraftKings Inc Markets
From CNBC.com News
Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more
Tags Economy Breaking News: Markets Meta Platforms Inc
From CNBC.com News
Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug
Tags Asia Markets World Markets Pharmaceuticals
From CNBC.com News
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
Tags Business Biogen Inc Health care industry
From CNBC.com News
Stocks making the biggest moves midday: JD.Com, Biogen, Oracle and more
Tags stocks Market Insider Markets
From CNBC.com News
FDA advisors to weigh whether Alzheimer's drug Leqembi should receive full approval
Tags Social issues US Economy US: News
From CNBC.com News
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
Tags US: News Social issues US Economy
From CNBC.com News
Jim Cramer expects defensive stocks to be resilient as debt ceiling talks drag on
Tags Business Food and Beverage Food and drink
From CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
Tags Eli Lilly and Co US: News Politics
From CNBC.com News
Stocks making the biggest moves premarket: Starbucks, AMD, Pearson, PacWest & more
Tags Stock markets Cogent Communications Holdings Inc Eli Lilly and Co
From CNBC.com News
Bipartisan attorneys general call on Medicare to cover Alzheimer's treatments
Tags US: News US Economy Health & Science
From CNBC.com News
Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease
Tags Business Eisai Co Ltd Disease outbreaks
From CNBC.com News
Alzheimer's: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says
Tags Health care industry Pandemics Biogen Inc
From CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
Tags Breaking News: Business Business News Science
From CNBC.com News
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease
Tags Health & Science Pharmaceuticals Drug approvals
From CNBC.com News
Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
Tags Health & Science Pharmaceuticals US: News
From CNBC.com News
Eli Lilly says experimental Alzheimer's drug reduces brain plaque in early study
Tags Health care industry Biogen Inc Breaking news
From CNBC.com News
FDA advisors reject Biogen's ALS drug for rare and aggressive form of the disease
Tags Biotechnology Biotech and Pharmaceuticals Breaking News: Business
From CNBC.com News
FDA staff says Biogen's ALS drug may have a 'clinical benefit' on a rare form of the disease
Tags Health & Science Pharmaceuticals US: News
From CNBC.com News
Veterans' Health will cover Alzheimer's treatment Leqembi for some patients
Tags World News Health care industry Pandemics
From CNBC.com News
FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July
Tags Biotech and Pharmaceuticals Coronavirus Biotechnology
From CNBC.com News
Medicare rejects Alzheimer's Association request for unrestricted coverage of treatments like Leqembi
Tags US Economy US: News US Top News and Analysis
From CNBC.com News
Stocks making the biggest moves midday: Deere, Airbnb, AutoNation, Moderna and more
Tags Redfin Corp Economy Breaking News: Markets
From CNBC.com News
Senators call on Medicare to offer broad coverage of Alzheimer's treatments as public pressure grows
Tags Coronavirus Biotech and Pharmaceuticals Biotechnology
From CNBC.com News
Maker of promising Alzheimer's drug Leqembi expects full FDA approval this summer, expanded Medicare coverage
Tags US Economy US: News U/S/ Economy
From CNBC.com News
Stocks making the biggest moves premarket: Kraft Heinz, Paramount, Airbnb, Tripadvisor and more
Tags Taiwan Semiconductor Manufacturing Co Ltd Breaking news Tripadvisor Inc
From CNBC.com News
FDA approves Alzheimer's drug that slowed cognitive decline in clinical trial
Tags Health & Science Breaking News: Politics Policy
From CNBC.com News
Stocks making the biggest moves midday: Mission Produce, Nutanix, Alphabet, Tesla and more
Tags Biogen Inc Business Toro Co
From CNBC.com News
Stocks making the biggest moves premarket: Tesla, Nutanix, Meta and more
Tags stocks Nutanix Inc Markets
From CNBC.com News
Stocks making the biggest moves midday: CrowdStrike, Horizon Therapeutics, Petco and more
Tags Hormel Foods Corp stocks Hewlett Packard Enterprise Co
From CNBC.com News
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.